BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27

• 

  Cell therapy

  How Kyverna rode CAR T’s autoimmune wave to the FDA’s door

  Poised to become the first company to achieve a regulatory filing for a cell therapy in autoimmune disease, Kyverna Therapeutics is building a pipeline-in-a-product to change the treatment paradigm.

  July 20, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Diabetes

  Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence

  After the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape with innovative approaches—and experts say there’s room for all of them.

  July 20, 2026

   · 

  7 min read

   · 

  Michael Gibney
• Press Releases

  Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region

  July 20, 2026

   · 

  10 min read
• Press Releases

  Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC

  July 20, 2026

   · 

  5 min read
• Press Releases

  Biovica Receives First Work Order Under Expanded Master Services Agreement with Leading Global Pharmaceutical Customer

  July 20, 2026

   · 

  2 min read
• Press Releases

  Antengene Announces Poster Presentation of ATG-022 and ATG-037 at ESMO 2026

  July 20, 2026

   · 

  4 min read
• Press Releases

  Medtrum Advances 300U Tubeless Patch Pump Toward German Launch

  July 20, 2026

   · 

  3 min read
• Press Releases

  Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

  July 20, 2026

   · 

  6 min read
• Press Releases

  CELLnTEC Launches New Website to Improve Access to Advanced Cell Culture Solutions, Technical Resources, and Application Support

  The new digital platform reinforces CELLnTEC’s positioning as the pioneer in chemically defined, animal-free tissue culture and a leader in epithelial and skin tissue engineering.

  July 20, 2026

   · 

  1 min read
• Press Releases

  Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar

  July 20, 2026

   · 

  9 min read